CA9 and neoplasm: Oav-decorin in combination with CAIX-CAR significantly reduced tumor load, altered extracellular matrix (ECM) composition by inhibiting collagen fiber distribution, reduced TGF-β expression, enhanced IFN-α secretion, and generated more CAR-T cells.